All articles by Andy Extance – Page 2
-
BusinessPositive trial sets stage for therapeutic use of MDMA in US
Hallucinogen-assisted psychiatric treatment heads to regulators, amid cost and other concerns
-
FeatureThe drug developers fighting the antibiotic resistance problem
Andy Extance talks to the researchers innovating across different drug classes in the hunt to develop new treatments
-
FeatureCan biorefineries eliminate fossil fuels and petrochemicals?
Plans to develop the world’s largest vegetable oil refinery reveal diverging views on the sustainability, profitability and scale of plant-based supply chains, finds Andy Extance
-
ResearchOrganic catalyst could cut the chlor-alkali process’s enormous appetite for energy
Cheap molecule achieves similar performance as existing costly metallic catalysts – but faces major questions about its stability
-
NewsNew results vindicate suspect 63-year-old claim on synthesis of first catenane
Researchers hoping to debunk Edel Wasserman’s doubted claims of the first interlinked rings end up supporting them
-
ResearchRapid alternating polarity brings new life to 189-year-old electrochemical reaction
A more sustainable approach to the Kolbe reaction could reduce chemists’ reliance on oil-derived materials
-
ResearchMachine learning ecosystem evolves MOF design
Mofdscribe handles all stages from collecting data to evaluating performance
-
ResearchRecord room-temperature superconductor could boost quantum computer chips
New material reduces pressures needed more than a hundredfold, but experts urge caution over structural questions and previously retracted research
-
NewsUK begins exploration of whether to build its own billion-pound-plus XFEL
Advanced designs could transform x-ray science economics, reducing the cost per experiment
-
NewsUS accelerator accident hospitalises worker, delays XFEL startup
The SLAC National Accelerator Laboratory lab director has stood down after the latest in a series of safety incidents and complaints
-
BusinessMerck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
-
ResearchAI model accurately classifies reaction mechanisms
Machine learning ‘surpasses chemist experts’ in identifying chemical processes
-
FeatureThe brain chemicals that control what we enjoy
Researchers are trying to understand how orexins influence our appetites, and whether we can use them to treat addiction and obesity, explains Andy Extance
-
FeatureHow a murder and a bombing cleaned up DNA profiling
The UK pioneered a forensic process to identify suspects from tiny amounts of DNA, but occasional flaws had big consequences. Andy Extance pieces together the whole story for the first time
-
FeatureLife’s chemistry goes through the looking glass
Chemists were taught that natural systems only use L-amino acids. Andy Extance finds out just how wrong that is proving
-
ResearchVibrational reactivity control harnesses quantum realm to speed up chemistry
‘Quantum phase control’ supercharges reaction between chlorine and singly deuterated methane at ambient temperature
-
ResearchUnusual hydrogen bonds found in proteins help them bind their targets
Weak interactions between hydrogen and carbon atoms have synthetic chemistry implications
-
BusinessPatent office cements priority for Crispr gene editing in cells
Nobel laureates’ failed challenge means companies may need extra patent licenses
-
ResearchVibrational spectroscopy distinguishes different diffusing isotopes
Scanning transmission electron microscopy-based method tracks graphene growth with atomic precision
-
ResearchIBM teaches reaction planning system to ‘speak enzyme’
RXN seeks to use enzyme catalysis to make chemistry more sustainable and resource efficient